In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
出版年份 2014 全文链接
标题
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
作者
关键词
-
出版物
NATURE MEDICINE
Volume 20, Issue 10, Pages 1138-1146
出版商
Springer Nature
发表日期
2014-09-13
DOI
10.1038/nm.3679
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hepatocellular carcinoma: clinical frontiers and perspectives
- (2014) Jordi Bruix et al. GUT
- A Direct In Vivo RNAi Screen Identifies MKK4 as a Key Regulator of Liver Regeneration
- (2013) Torsten Wuestefeld et al. CELL
- Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?
- (2013) Carmen Berasain GUT
- Resistance to RAF Inhibitors Revisited
- (2013) Edward Hartsough et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- T-helper-1-cell cytokines drive cancer into senescence
- (2013) Heidi Braumüller et al. NATURE
- Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial
- (2013) William MacNee et al. THORAX
- MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
- (2012) Sidong Huang et al. CELL
- Dibenzosuberones as p38 Mitogen-Activated Protein Kinase Inhibitors with Low ATP Competitiveness and Outstanding Whole Blood Activity
- (2012) Stefan Fischer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
- (2012) Cécile Guichard et al. NATURE GENETICS
- A pipeline for the generation of shRNA transgenic mice
- (2012) Lukas E Dow et al. Nature Protocols
- Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
- (2011) Eric T. Sawey et al. CANCER CELL
- Mutant BRAF Melanomas—Dependence and Resistance
- (2011) Poulikos I. Poulikakos et al. CANCER CELL
- Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies
- (2011) R. Lord et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
- (2011) Tae-Won Kang et al. NATURE
- Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor
- (2011) Solveigh C Koeberle et al. Nature Chemical Biology
- Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer
- (2010) Diego F. Calvisi et al. JOURNAL OF HEPATOLOGY
- Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders
- (2009) David M. Goldstein et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anti-Inflammatory Properties of a Novel N-Phenyl Pyridinone Inhibitor of p38 Mitogen-Activated Protein Kinase: Preclinical-to-Clinical Translation
- (2009) H. R. Hope et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor
- (2008) Nicholas C Turner et al. EMBO JOURNAL
- A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice
- (2008) Claudia Mitchell et al. Nature Protocols
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Topoisomerase levels determine chemotherapy responsein vitroandin vivo
- (2008) Darren J. Burgess et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evolution of systemic therapy of advanced hepatocellular carcinoma
- (2008) Thomas Yau et al. WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now